Login
From:
Rare Cancer News
(Uncensored)
subscribe
FDA grants Poseida's CAR T-cell therapy RMAT status for RRMM
https://rarecancernews.com/news/fda-grants-poseida-car-t-cell-therapy-rmat-status-rrmm/
links
backlinks
Tagged with:
car t-cell therapy
rrmm
myeloma
Roast topics
Find topics
Find it!
The FDA granted regenerative medicine advanced therapy status to the CAR T-cell therapy P-BCMA-ALLO1 for hard-to-treat multiple myeloma.